Ciclopirox Olamine Cream
Product Images NDC 0713-0638

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ciclopirox Olamine (NDC 0713-0638). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cosette Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton 15g

Carton 15g
This is the description of a medication called Ciclopirox Olamine Cream. It is used for dermatologic purposes only and not to be used in eyes. The cream is stored at a controlled room temperature and the tube seal comes with directions for puncturing it. The recommended dosage is to massage the cream twice a day in the affected and surrounding areas. Each gram of the cream contains 7.70mg of Ciclopirox Olamine in a base consisting of purified water, mineral oil, and other compounds. It comes in a tube with NDC number 0713-0638-15 and is available only by prescription.*
FDA Label Image

Carton 30

Carton 30
Ciclopirox Olamine Cream is a dermatologic cream that contains 0.77% ciclopirox olamine and is for external use only. The cream is manufactured by Gosette Pharmaceuticals and comes in a tube. The usual dosage is two applications daily, and the cream should not be used in the eyes. The cream comes with instructions on how to puncture the tube seal to use it, and it should be stored at room temperature. Each gram of the cream contains 7.70 mg of ciclopirox olamine in a water-miscible cream base. The cream is also available under the NDC number 0713-0638-31.*
FDA Label Image

Carton 90

Carton 90
Ciclopirox Olamine Cream is a dermatalogical cream with 0.77% concentration for use only in affected skin area excluding the eyes. It is safe to store it at room temperature and away from children. The product comes with a puncturing tube seal on the cap. The dosage requirement is twice daily in affected skin areas. The cream comprises various components including ciclopirox, water, benzyl alcohol, lactic acid, mineral oil, and more. The product is manufactured by Cosette Pharmaceuticals, Inc.*
FDA Label Image

Structure (Structural)

FDA Label Image

Tube 15

Tube 15
This is a description of a dermatologic medication in the form of a cream with ciclopirox olamine as its active ingredient, indicated for the treatment of skin infections. The medication should not be used in the eyes and should be kept out of the reach of children. The text includes dosage information, the medication's components, its concentration, an identification code (NDC) and manufacturer's address.*
FDA Label Image

Tube 30

Tube 30
Ciclopirox Olamine is a cream medication used for dermatological purposes only. It contains 0.77% of Ciclopirox Cream as its active ingredient. This cream should not be used in eyes, and it is essential to keep it out of reach of children. The usual dosage requires gentle massaging of the affected skin areas and surrounding regions twice daily (morning and evening). Ciclopirox Olamine comes in a cream base which includes various components, such as purified water USP, octyldodcanol NF, mineral il USP, to name a few. One should not use this cream if the seal has been tampered with. The packaging includes a Lot No. and Exp. Date. The manufacturer is Cosstts Pharmaceuticals, and the cream is stored at controlled room temperature.*
FDA Label Image

Tube 90

Tube 90
This is a medication containing 7.70 mg of ciclopirox in a cream base that is applied twice daily to affected skin areas. It is important to store it at 20-25°C, keep it out of reach of children, and not use it if the seal is punctured or not visible. The cream is not for use in eyes and the prescribing information should be reviewed before use.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.